Measuring Quality of Life Following Robot-Assisted Radical Prostatectomy.

ABSTRACT:

Background

Prostate cancer (PCa) represents the most common solid organ malignancy in men. Fortunately, at the time of diagnosis, the majority of cases are staged as localized or regional disease, conferring excellent 5- and 10-year cure rates. There are several first line treatment options including surgical approaches such as robot-assisted radical prostatectomy (RARP) and radiation therapy (RT) available to patients with localized disease that offer similar PCa oncologic outcomes but are associated with potentially significant side effects which may impact health-related quality of life (HRQOL) domains. Recently, clinicians and investigators have sought to better understand these changes in HRQOL metrics with the utilization of patient-reported outcomes (PRO). Given that RARP re

SUBMITTER: Hale GR 

PROVIDER: S-EPMC8236265 | biostudies-literature | 2021

REPOSITORIES: biostudies-literature